Cite
HARVARD Citation
Glintborg, B. et al. (2013). Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry. Annals of the rheumatic diseases. 72 (7), pp. 1149-1155. [Online].